Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | -1.85 | N/A | N/A | N/A |
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
-
-
-
The day is not over yet, and yes. The Bears were expected to put a fight last Friday, they still need to close below $122 before the new president start signing new orders in witch more vaccines purchases are a top priority.
-
$MRNA. In California they reported fewer than 10 people (that means 6-9)from a batch of 330,000 doses showed an allergic reaction to the vaccine. All 6-9 people are from the same location.
This seems very suspicious because the batch of 300,000 doses were distributed to 287 locations. But only one location is reporting the allergic reactions? If it was the batch bad. I would think other locations would be reporting the same problem.
I hope Moderna investigation on the batch comes out soon.
Personally my first thought was that California needs way more vaccines, and by saying this batch seem to be bad, we would like to get another one ASAP, this way they secured more vaccines. What do you think? Or do you think someone got paid for the bad news? -
$MRNA. In California they reported fewer than 10 people (that means 6-9)from a batch of 330,000 doses showed an allergic reaction to the vaccine. All 6-9 people are from the same location.
This seems very suspicious because the batch of 300,000 doses were distributed to 287 locations. But only one location is reporting the allergic reactions? If it was the batch bad. I would think other locations would be reporting the same problem.
I hope Moderna investigation on the batch comes out soon.
Personally my first thought was that California needs way more vaccines, and by saying this batch seem to be bad, we would like to get another one ASAP, this way they secured more vaccines. What do you think? -
RED TO GREEN
NO WHAT YOU HAVE
MRNA TO THE MOON -
My prediction:
It will start red.
Then after 3 hours we will see the turnSo. I’m very optimistic with this stock.
MRNA -
Green Day !!!
GO MRNA. !!!
-
I do not understand people. !
Why they sell ?
Really ???
Do your DD. This stock is HUGE. I’m so sorry that all those people selling act on panic
But ,,, well this is people.
I’m buying more. !!
MRNA. !!! GO !!!
-
MRNA
Waiting for red green oneBulls. Come on. !
We know what we have.
Wake up !!!!!!
-
We will green today. Well I believe so.
IMO.
Good morning -
$MRNA, About the CEO selling a small portion of his stocks.
1.- Good for him, he is getting some profits after so many years of hard work. Now tell me if you are in his position. Wouldn’t you sell some?
2.- If he is selling, someone else must be buying it ( institutions are loading the boat ) then those are the one that manipulated the stock prices later.
3.- He still owns more than 18M shares. Selling 10-20K is nothing. Now if he sells all 18M+ you should be concerned.
4.- He keeps getting more shares as part of his salary.$MRNA is saving lives, is saving the world and you want to be a bear about?
Remember that as a bear you can only double your money at best, but lose infinitely. -
$MRNA, real investors watch out for some crying bears. They shorted at $100 and now are 30% in the red.
This week when the new president finally enters the White House. I believe that is when $MRNA will hit the $150+ since the vaccination will be accelerated and the new government will order the 400M extra doses from $MRNA. By then $MRNA price will be hitting the $200 making all the poor bears lose 100% of their money.
$MRNA announced that is increasing production by 20% !!! That is really good news. The prices for the vaccines are: $10-50 vs Pfizer $20. The US alone has already ordered 200M doses from each just to start. But $MRNA has the option to sell 400M more doses just to the US. Based on the high volume the US is buying. The price is $15. By the way, the EU is trying to pay under $25/ dose. After that the vaccine will be available to the public at $32-37 per dose, we can say $70 for the full yearly protection. Now you know the number, go do some simple maths and see for yourself how much money this vaccine alone will bring to $MRNA investors this year and for ever. They might start paying dividend soon with all this new found fortune. -
$MRNA pretty much sold out its vaccine production for 2021. And bears are here dreaming of JnJ to start phase 3 trails and to pass. I do hope they do pass, so we have more vaccines to fight the pandemic. But $MRNA is here to stay.
If JnJ make it, they will just fill the blanks. Their efficacy is 90%. The target price is unknown. -
$MRNA, real investors watch out for some crying bears. I see 3 bears that keep posting here links. Don’t open those link. They might just have spyware.
$MRNA announced that is increasing production by 20% !!! That is really good news. The prices for the vaccines are: $10-50 vs Pfizer $20. The US alone has already ordered 200M doses from each just to start. But $MRNA has the option to sell 400M more doses just to the US. Based on the high volume the US is buying. The price is $15. By the way, the EU is trying to pay under $25/ dose. After that the vaccine will be available to the public at $32-37 per dose, we can say $70 for the full yearly protection. Now you know the number, go do some simple maths and see for yourself how much money this vaccine alone will bring to $MRNA investors this year and for ever. They might start paying dividend soon with all this new found fortune. -
Mmmm is it going to skip the $130s?
-
Last time it jumped from $127.03 on a Friday to a $144 opening on a Monday. It will be so crazy if they do it again!!!
-
Go take a look to refresh your memory
-
Go take a look to refresh your memory
-
Just in case bears don’t remember $MRNA skipped the $130s last November 30th.
-
3 Beaten-Down Stocks Ready for a Comeback
marketbeat.com • -
NTx Services Launches to Supercharge Next Generation mRNA Research
businesswire.com • -
Moderna (NASDAQ:MRNA) Shares Up 7%
news.google.com • -
Moderna (NASDAQ:MRNA) PT Lowered to $48.00
news.google.com • -
What's Going On With Moderna Shares Tuesday?
news.google.com • -
Where are the Opportunities in (MRNA)
news.google.com • -
Moderna (MRNA) Rises Higher Than Market: Key Facts
news.google.com • -
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein
news.google.com • -
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein
news.google.com • -
Moderna: Cutting Costs At Just The Worst Time (NASDAQ:MRNA)
news.google.com • -
Class Action Lawsuit Against Moderna, Inc. (NASDAQ:MRNA)
news.google.com • -
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
news.google.com • -
Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut
news.google.com • -
‘Time to Move to the Sidelines,’ Says Jefferies About Moderna Stock
news.google.com • -
MRNA Stock Falls 12% on Lowered Sales Outlook, R&D Budget Cuts
news.google.com • -
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts
news.google.com • -
Moderna's Move Shows Lack Of Confidence, Shrinks Pipeline (NASDAQ:MRNA)
news.google.com • -
Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around.
news.google.com • -
Moderna: Oddo BHF reduces its target after CMD
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Moderna Stock Hits Lowest Since 2020. What’s Behind the Tumble.
news.google.com • -
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns
news.google.com • -
Moderna Stock Plummets on Cost-Cutting Measures
news.google.com • -
Biggest stock movers today: WBD, MPW, MRNA, SIG, and more
news.google.com • -
Moderna stock plunges after slashing R&D budget
news.google.com • -
Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs
news.google.com •